On the other hand, mounting evidence indicate that some miRNAs could effectively repress the expression of EZH2 in tumors such as breast, prostate, endometrial, gastric, colon, hepatocellular, bladder and oral cancers [21-26]. The gene discussed is EZH2; the disease is lip and oral cavity carcinoma.